1-20 of 168
Keywords: Multiple myeloma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol 1–5.
Published Online: 20 June 2023
... allows the generation of multi-energy images with increased contrast and scanning speed or ultra-high spatial resolution (UHR) images with lower radiation doses, compared to the currently used energy integrating detector (EID) CT. Since the recognition of bone disease related to multiple myeloma...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2022) 145 (6): 619–626.
Published Online: 29 July 2022
... multiple myeloma (SMM, n = 2) and low-risk monoclonal gammopathy of undetermined significance (MGUS, n = 6). Six patients were on tyrosine kinase inhibitor treatment, 2 were in treatment-free remission. The only covariate associated with paraproteinemia was the presence of anemia, albeit with borderline...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2021) 144 (3): 264–274.
Published Online: 04 December 2020
... study in relapsed/refractory multiple myeloma (MM). Here, we present data from a phase II study (NCT02290431) of this combination in Japanese patients with relapsed or relapsed-and-refractory MM. Methods: Patients received 3-week cycles of 20-mg oral panobinostat (weeks 1 and 2), 1.3-mg/m 2 subcutaneous...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2021) 144 (3): 252–258.
Published Online: 13 July 2020
... between ESA and glucose in anemia-treated patients with myelodysplastic syndromes (MDS) or multiple myeloma (MM). Patients and Methods: Patients’ glucose levels were compared while on to while off ESA, and all served as their own controls. To test the association between ESA and blood glucose, we employed...
Journal Articles
Journal Articles
Acta Haematol (2020) 143 (5): 410–416.
Published Online: 17 April 2020
...Abdullah S. Al Saleh; Taimur Sher; Morie A. Gertz We provide our recommendations (not evidence based) for managing multiple myeloma patients during the pandemic of COVID-19. We do not recommend therapy for smoldering myeloma patients (standard or high risk). Screening for COVID-19 should be done...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2020) 143 (2): 118–123.
Published Online: 31 March 2020
... and immunotherapy is increasingly recognized. Plasma cells in multiple myeloma have the potential to survive in the gastrointestinal tract for long periods of time. The nature of the gut microbiota impacts the degree of antigen stimulation of these cells and may play a role in mutation development and clonal...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2019) 141 (2): 111–118.
Published Online: 06 February 2019
... transplantation (ASCT) in newly diagnosed Japanese patients with multiple myeloma (MM). This regimen consisted of four 28-day cycles of once-weekly oral cyclophosphamide (300 mg/m 2 ), subcutaneous bortezomib (1.3 mg/m 2 ), and oral dexamethasone (40 mg). Responding patients underwent stem cell collection...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2019) 141 (1): 1–6.
Published Online: 15 January 2019
... Matutes Multiparameter flow cytometry (MFC)-based clonality assessment is a powerful method of diagnosis and follow-up in monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). However, the relevance of intraclonal heterogeneity in immunophenotypic studies remains poorly...